GC Therapeutics
Cambridge, Massachusetts, United States · Biotechnology, Health Care, Therapeutics · 38 employees
GC Therapeutics is a biopharmaceutical company focused on advancing cell therapy-based medicines. It utilizes an induced pluripotent stem cell programming platform, TFome™, which incorporates synthetic biology, gene editing, cell engineering, and machine learning. The company aims to tackle the complexities of therapeutic development and scaling in cell therapy to enhance patient access to treatme
Funding history
- Series series a — $65.0M — Sep 2024
Recent signals
- May 05, 2026: GC Therapeutics Appoints Stefan Irion, MD as Chief Scientific Officer
- Sep 23, 2024: Raised $65.0M in Series series a
See plans & pricing → Track GC Therapeutics’s funding, hiring, and signals — with verified contacts — on Fundz.